ICONIQ Growth

– Monte Carlo, the data reliability company, announced that they have raised $60M in Series C funding from ICONIQ Growth with participation from Salesforce Ventures and existing investors Accel, GGV Capital, and Redpoint Ventures – bringing their total funding to $101M.
– With this round, Monte Carlo will fuel the growth of the Data Observability category, further develop its product offerings for our customers, support more use cases, and expand to new markets.
– Monte Carlo’s Series C establishes the company as the first Data Observability company to reach this milestone, a testament to the team’s industry-defining thought leadership, new product releases, and rapid customer growth.

– Reify Health announced a $220m Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures.
– This latest funding, which brings the company’s valuation to $2.2bn, underscores Reify Health’s success in dramatically shortening clinical trial timelines.
– Reify Health has built a new foundation for how clinical trials are run through its business entities, StudyTeam and Care Access.
– StudyTeam delivers the best-in-class technology platform for optimizing patient recruitment and enrollment, and is used by top-20 global biopharma companies such as Amgen, AstraZeneca, and Eli Lilly and Company, and approximately 4,000 research sites across 65 countries.